{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:13:48Z","timestamp":1788970428678,"version":"build-2803163510"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"DOI":"10.1097\/dss.0000000000005339","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:34:53Z","timestamp":1788968093000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Reduced Risk in Melanoma and Nonmelanoma Skin Cancers in Obese Patients on Semaglutide and Tirzepatide"],"prefix":"10.1097","author":[{"given":"Rashwan","family":"Alameddine","sequence":"first","affiliation":[{"name":"Texas A&M Naresh K. Vashisht College of Medicine, Bryan, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Roecker","sequence":"additional","affiliation":[{"name":"Texas A&M Naresh K. Vashisht College of Medicine, Bryan, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Jabin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"R1-20260909","doi-asserted-by":"crossref","first-page":"48","DOI":"10.20431\/2456-0022.0802005","article-title":"A systematic review of the cutaneous adverse effects of GLP-1 agonists","volume":"8","author":"DeVore","year":"2025","journal-title":"ARC J Dermatol"},{"key":"R2-20260909","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/cancers17010078","article-title":"Differential effects of GLP-1 receptor agonists on cancer risk in obesity: a nationwide analysis of 1.1 million patients","volume":"17","author":"Levy","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R3-20260909","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, diabetes, and increased cancer progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab J"},{"key":"R4-20260909","doi-asserted-by":"crossref","first-page":"20420188231222367","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DSS.0000000000005339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:34:54Z","timestamp":1788968094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DSS.0000000000005339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":4,"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000005339","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}